Alice THEODORESCU: The symbolic “terrorism” of globalization

 Professors Jaap Kooijman and Thomas Poell
Classic Texts in Media Theory
October 2011



What is, in fact, 9/11? Event, brutal reality, ”the greatest aesthetic gesture of the twentieth century” (Fredric Jameson, 304)? When trying to achieve a holistic perspective of the historical, indeed awful event that took place on September 11th, 2011, one cannot but wonder about the true, political reasons behind the ”terrorist” gesture and its meaning on a global scale. It was not so much about an act of crime against humanity, but rather about the thin line between what really happened and what media, politics and history made out of it.
As opposed to the official discourse on “terrorism” and the “loss of innocence”, there are three approaches of 9/11 that I will take into account: defining the event through its symbolic meaning in a mediated reality (Baudrillard), the event as the culminating intrinsic fantasy of self-destruction in the Western culture (Zizek) and the historical frame of the event which is ignored by the media discourse of disaster (Jameson).
Firstly, when facing this event, it is the power of the symbolic - as defined by Baudrillard -, which is hidden by the official frame of references (victims versus terrorism). It is not about the real horror, but about the images of horror that become more important than reality itself, because that which is considered real is, in fact, another layer of the spectacle. As Baudrillard further points out in ”The Spirit of Terrorism”: “In this case, one thought (…) that there was a resurgence of the real – of the violence of the real – in a supposedly virtual universe. (…) If this seems to be the case, it is because reality absorbed the energy of fiction and became fiction” (140-141). 9/11 represents the climax of fiction-reality as media transformed it into a shocking spectacle that was transmitted in real time on a global scale. Hollywood had transcended the big screen and a catastrophe “movie” was broadcasted on televisions across the world. It was as if reality was not real anymore.
In Zizek’s terms, it was a ”derealization” (65), as the illusion of the safe, reliable “Western sphere” shattered. Moreover, the impact was even stronger as the collective desires nurtured by the fantasy of disaster had become real. Thus Western civilization, or better said, US civilization had to deal with the “impersonation” of its own self-destruction as a result of “the Evil” within. The hegemonic power dealt with its consequences.
In fact, considering 9/11 is not even a matter of America versus Islam or capitalism against fundamentalist terrorism. It is a clash within a so-called world order that cannot sustain itself, for it has too many antagonisms that cannot be and shouldn’t be unified, especially not under a hegemonic power. It is an alarm signal raised against such tendencies although the “terrorist attack threat” sounds more concrete and allows governs to find a solution and “fight” against it. How can you fight against this Evil within? It is easier to give it a name, the name of the Other and to strike back. As Zizek states it “(…) we should gather the courage to endorse the Hegelian lesson: in this pure Outside, we should recognize the distilled version of our own essence” (65). As such, the Western’s hidden alter-ego surfaced the conscious image of the innocent.
Going even beyond this antagonistic discourse, what everyone seems to forget, even now, is that it was not a spontaneous act of terrorism, but a consequence of “global peace” as a utopian form of history that humanity cannot actually sustain. As the historical approach of Jameson unfolds: “One does not have to endorse Hegel’s infamous comment that wars are necessary for the spiritual health of societies, to see how the absence of generalized physical destruction creates a certain problem for capitalism (…).” (Fredric Jameson, 303) Capitalism and globalization are, indeed, their own enemy to a certain extent and they need, as cynical as it may sound, violent “valves” of depressurizing “unused inventories” (Fredric Jameson, 303) both at a material level, but at a political, ideological level as well. Jameson underlines this by arguing that after the eradication of the Leftist, the logic of antagonisms seemed futile, so another Other needed to arise, this time on the grounds of politics of religion (302). Baudrillard couldn’t have stated this paradox better: “If Islam dominated the world, terrorism would rise up against Islam, since it is the world which resists globalization” (136).
9/11 has, thus, become the first step into a mediated reality-fantasy as a pretext of retaliation on the symbolic “Other”. Although there is an unconscious need for destruction, it further nurtures the official discourse of “war on terrorism” in a constant struggle to justify the hegemonic strive of globalism as protector of “freedom” and “world peace”.

Works cited
Baudrillard Jean, “The Spirit of Terrorism”, Telos, Fall 2001: 134-142.
Fredric Jameson, “The Dialectics of Disaster,” The South Atlantic Quarterly 102: 2 (2002): 297-304.
Slavoj Žižek, “Welcome to the Desert of the Real: Reflections on WTC,” third version (October 2001), lacanian ink 16 (Spring 2000 [sic]): 64-81

Sesila ÇIBUKU, Gentian KASMI PhD: Bacterial Resistance and Doripenem (Doribax)

 
The aim of the paper: The identification of the importance of bacterial resistance and the need for cost-effective antibiotics.

Materials and methods: To perform this study have been considered 444 patients under treatment with antibiotics, who have used 621 antibiotics (about 1.4 antibiotics per patient) in the Mother Theresa University Hospital Centre.

Results: The minimum inhibitory concentration (MIC) of doripenem against microorganisms like S.aureus, P.aeruginosa, E.coli, Enterobacter, P.mirabilis is lower than other carbapenems. Comparative studies with Imipenem and Tazocine resulted that Doripenem costs less and the hospitalization days are shorter.

Key words: bacterial resistance, doripenem, cost-efficacy

Introduction

In the past years, antibiotics have been critical in the fight against infectious disease caused by bacteria and other microbes. Antimicrobial chemotherapy has been a leading cause for the dramatic rise of average life expectancy in the Twentieth Century. However, disease-causing microbes that have become resistant to antibiotic drug therapy are an increasing public health problem. Wound infections, gonorrhea, tuberculosis, pneumonia, septicemia and childhood ear infections are just a few of the diseases that have become hard to treat with antibiotics.
Nowadays, about 70 percent of the bacteria that cause infections in hospitals are resistant to at least one of the drugs most commonly used for treatment. To prevent and to treat infections is very important to know which is the best antibiotic to use, but the increasing use and the misuse of antibiotics are the most common ways that led to bacterial resistance. When the microorganism is capable to survive the antibiotic this is due to genetic mutation, as the major cause. Bacterial resistance could be a result of gene horizontal transfer (conjugation, transduction, transformation).
The main mechanisms of bacterial resistance are: the drug inactivation or modification through bacterial enzymes like β-lactamase, the alteration of the target (PBP changes to MRSA in penicillin), the alteration of metabolic pathways (the sulfonamide resistant microorganisms do not seek for PABA-which is the precursor of the synthesis of folic acid and nucleic bacterial acid), a decrease in drugs accumulation.
The increase of the microbial development of resistance against antibiotics, resulting in the increase of the treatment costs, is the main reason why we undertook  this study in order to decrease the treatment costs of the infectious diseases.
Materials and methods
To perform this study have been considered 444 patients under treatment with antibiotics, who have used 621 antibiotics (about 1.4 antibiotics per patient). The patients  in the study were treated in the infectious diseases service, the pediatric infectious diseases service and the urology service in the Mother Theresa University Hospital Centre.

The study is conducted in these services because of the specifics of the pathologies, remembering that the intervenes in the urology service by nature are intervenes in not sterile fields, while in infectious services (like infectious diseases service and the pediatric service) very often is hard to select the right one antibiotic.

Results
From this study is obvious the increased bacterial resistance of microorganisms like E.coli, P.aeruginosa, P.mirabilis, E.faecalis. In the table below is noticed that ampicillin is not the first choice because the resistance against it is very high, but even cefuroxime and ciprofloxacin should not be considered as the best choices. 

Table No. 1
Percentage of bacterial resistance in the Mother Theresa University Hospital Centre (%)
Antibiotics

Antibiotics


E.coli
P.mirabilis
P.aeruginosa
E.faecalis
Amicacin

29

56

Amoxicillin

50

100

Ampicillin

100
100
100

Cefepim

50

11

Cefotaxim

57

100

Ceftazidim

57

11

Cefuroxim

57

100


Table No. 2
Percentage of bacterial resistance in the Mother Theresa University Hospital Centre (%)


Antibiotics


E.coli

P.mirabilis

P.aeruginosa

E.faecalis
Ciprofloxacin

50

89
83
Gentamicin

57

89
100
Meropenem



11

Tazocin

14

11

Sulf/Trimethoprim

64
100
100
100
Levofloxacin




57
Moxifloxacin




25
Cefaclor

86

100


Doripenem has three approved indications:
-Nosocomial pneumonia (NP), including ventilator-associated pneumonia (VAP)
-Complicated intra-abdominal infections (cIAI)
-Complicated urinary tract infections (CUTI).

Table No. 3
In vitro activity for different carbapenems
Doripenem displays low in vitro MICs (mcg/ml) for gram positive pathogens.



Doripenem
Meropenem
Imipenem
S.aureus

0.06-32
0.12-32
0.5-32
E.faecalis

8
16
4
S.pneumonie

0.008-1
0.008-1
0.5-1
S,viridans

0.5
0.5
0.5
S.betahemolitic

0.03
0.06
0.5
E.faecium

>16
>16
>8

Table No. 4
Doripenem displays low in vitro MICs (mcg/ml) for gram negative pathogens.
  

Doripenem
Meropenem
Imipenem
E.coli

0.03-0.06
0.03-0.06
<0.05
Klebsiella

0.06-0.12
0.12
<0.05
Enterobacter spp
Ceftazidim resistant
0.12-0.25
0.25
1
Citrobacter spp
Ceftazidim resistant
0.06-0.12
0.06-0.12
1
P.mirabilis

0.25
0.12
2
Serratia spp
Ceftazidim resistant
0.25-0.5
0.12-0.5
1-2
Salmonella spp

0.06
0.03
<0.05
Shigella spp

0.06
0.03
<0.05
P.aeruginosa

8
16
>8
Acinetobacter

4
8
2

Doripenem dosing regimen is: 500 mg (100 ml/1 hour), 250 mg (50 ml/1 hour). Recommended: 500 mg every 8 hours venous infusion lasting 1 hour, over 18 years old.

Discussion

Microbial development of resistance, as well as economic incentives, has resulted in research and development in the search for new antibiotics in order to maintain a pool of effective drugs at all times. Disease-causing microbes that have become resistant to antibiotic drug therapy are an increasing public health problem. One part of the problem is that bacteria and other microbes that cause infections are remarkably resilient and have developed several ways to resist antibiotics and other antimicrobial drugs. Another part of the problem is due to increasing use, and misuse, of existing antibiotics in human medicine, also the poor sanitary conditions in our hospitals.
The minimum inhibitory concentration of doripenem for bacteria like S.aureus, P.aeruginosa, E.coli, Enterobacter spp, P.mirabilis is lower than other carbapenems. Doripenem is the best combination of the intrinsic activity of meropenem against gram negative bacteria and the intrinsic activity of imipenem against gram positive bacteria. From the comparative studies with tazocin and imipenem resulted that doripenem costs less and lowers the hospitalization at least 15 %.
Knowing the efficacy of this antibiotic against resistant microorganisms, the good safety profile and the low cost of treatment, we recommend the hospital use of this antibiotic in the infectious diseases service.

References

U.S. Food and Drug Administration (October 17, 2007). "FDA Approves New Drug to Treat Complicated Urinary Tract and Intra-Abdominal Infections". Press release. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01728.html. Retrieved 2007-10-25. 
Johnson & Johnson (July 16, 2008). "Doripenem for Injection for the Treatment of Nosocomial Pneumonia". Press release. http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4364b1-02-Johnson.pdf. Retrieved 2010-05-19. 
2. Janssen-Ortho Inc. (September 1, 2009) "Doribax". Retrieved November 22,2009. http://www.janssen-ortho.com/JOI/pdf_files/Doribax_E.pdf
3. Chemical Process Research and Development. American Chemical Society. (September 24, 2003) "Practical Large-Scale Synthesis of Doripenem: A Novel 1β-Methylcarbapenem Antibiotic". Retrieved November 22, 2009. http://pubs.acs.org/doi/abs/10.1021/op034088n
4. European Medicines Agency. (2008) "CHMP Assessment Report for Doribax". Retrieved November 22, 2009. http://www.emea.europa.eu/humandocs/PDFs/EPAR/doribax/H-891-en6.pdf
5. Formulary Journal Vol. 42 (December 2007)"Doripenem: A new extended-spectrum carbapenem antibiotic". Retrieved November 26, 2009. http://web.ebscohost.com/ehost/pdf?vid=8&hid=4&sid=8ccb7619-3d37-431f-bf13-d0ddc9ffc481%40sessionmgr114
6. Drugs R & D (2003) "Doripenem: S 4661". Retrieved November 23, 2009. http://web.ebscohost.com/ehost/pdf?vid=14&hid=106&sid=ee346c2a-d844-4d2b-a065-bdd8e7bf2348%40sessionmgr4

Litteris Forum 2012

Litteris Forum 2012

- întâlnire culturală dedicată tinerilor pasionaţi de literatură şi arte -

Scopul acestui forum (de altfel, unul dintre punctele principale în programele de cercetare ale instituţiei noastre) este să contribuie la cunoaşterea, aprofundarea şi mediatizarea literaturii şi artelor româneşti în cadrul învăţământului preuniversitar românesc, precum şi să sprijine creaţia artistică a elevilor, în noile coordonate cultural-educaţionale din Europa actuală.

Forumul se desfăşoară sub deviza „Comunicare în arte şi Artă în comunicare”
Se va acorda Premiul Litteris pentru secţiunile:
  • Poezie
  • Proză
  • Eseu (literar, ştiinţific)
  • Scenariu (text de teatru, cinematografie, balet)
  • Traduceri (din limba română într-o limbă străină şi invers)
  • Coregrafie (spectacol realizat de participanţi – fragmente pe CD, sau Synopsis)
  • Arte Plastice (pictură, sculptură, grafică, design – fotografii ale operelor participante)
Premiul Litteris pentru această ediție constă în obiecte școlare necesare studiului și creației, în diplome personalizate și în asigurarea unui loc de student la una dintre specializările Universităţii Române de Ştiinţe şi Arte „Gheorghe Cristea”.

Înmânarea premiilor se desfășoară la sediul nostru din Str. Matei Basarab nr. 18 bis, sector 3, Bucuresti.
Rezultatele şi o descriere a evenimentului vor fi oglindite în mass-media scrise și electronice.
Sunt invitaţi să participe toţi tinerii pasionaţii de literatură şi arte, inclusiv românii sau cei de origine română care trăiesc în străinătate.

Lucrările trebuie trimise la e-mail-ul: comunicarts@gmail.com 
până la data de 30 aprilie 2012 
cu menţiunea Pentru Litteris Forum

Pentru a uşura şi eficientiza activitatea Juriului, avem rugămintea ca textele să nu depăşească 10 pagini A4, Times New Roman 12 / 1 rând. Ele trebuie să fie însoţite de datele de contact ale autorilor: Nume, Prenume, Liceu / Şcoala, Adresă poştală şi de e-mail, şi un număr de telefon.

Finaliştii pot aduce cu ei prieteni şi susţinători. La cerere, autorii pot citi sau interpreta din lucrările proprii în seara de premiere.